Splicing modulation therapy in the treatment of genetic diseases

被引：32
作者：
Arechavala-Gomeza, Virginia [1 ]
Khoo, Bernard [2 ]
Aartsma-Rus, Annemieke [3 ]
机构：
[1] BioCruces Hlth Res Inst, Neuromuscular Disorders Grp, Baracaldo, Bizkaia, Spain
[2] UCL, Div Med, Endocrinol, London, England
[3] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands
来源：
APPLICATION OF CLINICAL GENETICS | 2014年 / 7卷
关键词：
splicing; therapy; antisense oligonucleotides; cryptic splicing; alternative splicing;
D O I：
10.2147/TACG.S71506
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Antisense-mediated splicing modulation is a tool that can be exploited in several ways to provide a potential therapy for rare genetic diseases. This approach is currently being tested in clinical trials for Duchenne muscular dystrophy and spinal muscular atrophy. The present review outlines the versatility of the approach to correct cryptic splicing, modulate alternative splicing, restore the open reading frame, and induce protein knockdown, providing examples of each. Finally, we outline a possible path forward toward the clinical application of this approach for a wide variety of inherited rare diseases.
引用
收藏
页码：245 / 252
页数：8
相关论文
共 65 条
  • [1] Aartsma-Rus Annemieke, 2014, J Neuromuscul Dis, V1, P41
  • [2] Translational and Regulatory Challenges for Exon Skipping Therapies
    Aartsma-Rus, Annemieke
    Ferlini, Alessandra
    Goemans, Nathalie
    Pasmooij, Anna M. G.
    Wells, Dominic J.
    Bushby, Katerine
    Vroom, Elizabeth
    Balabanov, Pavel
    [J]. HUMAN GENE THERAPY, 2014, 25 (10) : 885 - 892
  • [3] Antisense-Mediated Exon Skipping: Networking to Meet Opportunities and to Overcome Challenges
    Aartsma-Rus, Annemieke
    [J]. NUCLEIC ACID THERAPEUTICS, 2014, 24 (01) : 1 - 3
  • [4] Antisense-mediated modulation of splicing Therapeutic implications for duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    [J]. RNA BIOLOGY, 2010, 7 (04) : 453 - 461
  • [5] Anthony K, NEUROLOGY
  • [6] Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression
    Arechavala-Gomeza, V.
    Kinali, M.
    Feng, L.
    Brown, S. C.
    Sewry, C.
    Morgan, J. E.
    Muntoni, F.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (04) : 265 - 274
  • [7] Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
    Arechavala-Gomeza, Virginia
    Anthony, Karen
    Morgan, Jennifer
    Muntoni, Francesco
    [J]. CURRENT GENE THERAPY, 2012, 12 (03) : 152 - 160
  • [8] Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
    Arechavala-Gomeza, Virginia
    Kinali, Maria
    Feng, Lucy
    Guglieri, Michela
    Edge, Geraldine
    Main, Marion
    Hunt, David
    Lehovsky, Jan
    Straub, Volker
    Bushby, Kate
    Sewry, Caroline A.
    Morgan, Jennifer E.
    Muntoni, Francesco
    [J]. NEUROMUSCULAR DISORDERS, 2010, 20 (05) : 295 - 301
  • [9] Cadherin-23, myosin VIIa and harmonin, encoded by Usher syndrome type I genes, form a ternary complex and interact with membrane phospholipids
    Bahloul, Amel
    Michel, Vincent
    Hardelin, Jean-Pierre
    Nouaille, Sylvie
    Hoos, Sylviane
    Houdusse, Anne
    England, Patrick
    Petit, Christine
    [J]. HUMAN MOLECULAR GENETICS, 2010, 19 (18) : 3557 - 3565
  • [10] Clinical and genetic heterogeneity in laminopathies
    Bertrand, Anne T.
    Chikhaoui, Khadija
    Ben Yaou, Rabah
    Bonne, Gisele
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1687 - 1692
1234567